Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFL24498 in Atopic Keratoconjunctivitis
NCT07395232Phase 3Recruiting
- Sponsor
- Dompé
- Start
- Dec 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of isocyclosporin in atopic keratoconjunctivitis (AKC), sponsored by Dompé. Started Dec 2025; status: recruiting.
02
Drugs
isocyclosporin
03
Conditions
atopic keratoconjunctivitis (AKC)
Beyond the preview
Go deeper on NCT07395232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07395232.